Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 NOK)

Closing information 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Turnover 537,500 Less Arrow 487,335 More Arrow 559,907
Financial expenses 34,452 Less Arrow 29,618 More Arrow 42,663
Earnings before taxes 5,654 More Arrow 32,748 Less Arrow -93,477
EBITDA 15,784 More Arrow 47,820 Less Arrow -28,553
Total assets 640,228 Less Arrow 592,009 Less Arrow 560,551
Current assets 490,651 Less Arrow 465,572 Less Arrow 426,519
Current liabilities 552,579 Less Arrow 305,210 Less Arrow 210,021
Equity capital 68,589 Less Arrow 45,233 Less Arrow -43,177
- share capital 23,233 Less Arrow 21,698 More Arrow 22,376
Employees (average) 122 More Arrow 126 More Arrow 128

Financial ratios

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Solvency 10.7% Less Arrow 7.6% Less Arrow -7.7%
Turnover per employee 4,406 Less Arrow 3,868 More Arrow 4,374
Profit as a percentage of turnover 1.1% More Arrow 6.7% Less Arrow -16.7%
Return on assets (ROA) 6.3% More Arrow 10.5% Less Arrow -9.1%
Current ratio 88.8% More Arrow 152.5% More Arrow 203.1%
Return on equity (ROE) 8.2% More Arrow 72.4% More Arrow 216.5%
Change turnover 15,717 Less Arrow -55,611 More Arrow 160,267
Change turnover % 3% Less Arrow -10% More Arrow 40%
Chg. No. of employees -4 More Arrow -2 More Arrow 4
Chg. No. of employees % -3% More Arrow -2% More Arrow 3%

Total value of public sale

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.